AZN vs XPEL · P/E 28, $288.38B cap vs P/E 24, rev $260.4M
AstraZeneca PLC (AZN) versus Xpel Inc (XPEL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Xpel Inc (XPEL) is a auto parts company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported XPEL revenue for 2026-06-30 was $260.4M. Net income was $28.4M. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
Not investment advice. Open the AZN and XPEL stock pages for the full models.
Not investment advice.